A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease

Clinical trial NCT02836574 · COMPLETED

Trial details

NCT number: NCT02836574
Sponsor: Prokidney
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Chronic Kidney Disease

Start date: 2016-09-01
Primary completion: 2023-12-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.